Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 1427 matches for

Oxford-Built Multi-Agent assistant for Cancer Care to be piloted in collaboration with Microsoft

Researchers at the Department of Oncology have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.

New Study to Investigate How Immunometabolism Shapes Treatment Responses in Pancreatic Cancer

Keaton Jones, Consultant Hepatobiliary and Pancreatic Surgeon at Oxford University Hospitals NHS Foundation Trust and Senior Clinical Researcher in the Department of Oncology at the University of Oxford, has received a Wellcome Trust Early Career Award to investigate the role of macrophage metabolism in determining therapeutic responses in pancreatic cancer.

Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary

Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.

World’s first lung cancer prevention vaccine gets £2 million for clinical trial

People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.

Oxford Oncology at ESMO 2025

Members of the Department of Oncology attended ESMO earlier this month to present their research, chair sessions, and network with collaborators from across Europe and beyond. Read the highlights from our department’s contributions to ESMO 2025.

Professor Sarah Blagden to star in New Landmark Channel 4 Documentary Series 'Cancer Detectives: Finding the Cures'

Channel 4 today announces 'Cancer Detectives: Finding the Cures', an observational documentary series that will explore the pioneering research that could transform the future of cancer detection, treatment and prevention.

Dr Peter Wan Awarded Pancreatic Cancer UK Fellowship to Develop New Immunotherapy for Pancreatic Cancer

Dr Peter Kok-Ting Wan, PhD, postdoctoral researcher at the Department of Oncology, has been awarded a prestigious fellowship from Pancreatic Cancer UK to develop a new immunotherapy for pancreatic cancer, which has the lowest survival rate of any common cancer. The project seeks to develop a novel antibody-based treatment that targets both the cancer cells and the dense, protective barrier that makes pancreatic tumours so difficult to treat.

Dr Elizabeth Smyth elected ESMO Director of Education

Dr Elizabeth Smyth has been elected as Director of Education for the European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncologists in Europe. In this role, Dr Smyth will be responsible for shaping and overseeing an inclusive, forward-looking educational strategy that supports oncologists worldwide.

Oxford Clinical Researcher Awarded NIHR EME Funding to Study Impact of Insulin Levels on Breast Cancer Treatment Response

Associate Professor Simon Lord has been awarded funding from the NIHR to launch a clinical study investigating the impact of insulin resistance on response to endocrine therapy in patients with oestrogen receptor (ER)-positive breast cancer.

New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.

Early-Career Researchers Awarded Competitive Funding for Pioneering Cancer Studies

We are proud to share the success of two early-career postdoctoral researchers at the Department of Oncology, Ahmet Hazini and Esther Ng, who have secured funding to deliver pioneering research projects that aim to advance the field of cancer immunotherapy.

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Machine Learning Enhances Detection of Multiple Cancer Types from Blood

Researchers from the University of Oxford have developed TriOx, a highly sensitive blood test that detects six cancers at their earliest stages. Published today in Nature Communications, the findings highlight the test’s potential to transform early cancer detection and improve patient outcomes.

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Oxford and NTU Singapore Study discovers new process for cells to repair DNA damage

A team of international researchers at the University of Oxford (Oxford) and Nanyang Technological University, Singapore (NTU Singapore), has discovered a new process for repairing damaged DNA that is particularly relevant for patients undergoing colorectal cancer treatments.

Subashan Vadibeler wins 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

New funding for development of world's first lung cancer vaccine

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.

Gulnar Abdullayeva receives an Azerbaijan Presidential Award for Youth 2024

Department of Oncology researcher Gulnar Abdullayeva has been honoured with the "Presidential Award 2024 for Youth" by the Decree of the President of the Republic of Azerbaijan for her distinction in the field of Science.

Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre

Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.

Load More